Resurgence of mucormycosis during COVID-19 pandemic

Abstract

ObjectiveTo explore the literature on corona-associated mucormycosis and explain its relevance to dentists and oral surgeons. MethodsA literature search was carried out to identify reported cases on corona-associated mucormycosis since the start of COVID-19 pandemic. ResultsA review of literature identified 265 published papers on CAM between March 2020 and September 2021. Careful screening of abstracts and full texts revealed 29 studies reporting case series of CAM and, 27 case reports on CAM. ConclusionsA multitude of factors may be responsible for the alarming rise in the incidence of corona-associated mycosis including reduced access to routine medical services during the pandemic, injudicious use of antibiotics, steroids and nutritional supplements. Risk factors contributing to corona-associated mucormycosis need to be recognized. Dentists and oral surgeons can contribute to early recognition of corona-associated mucormycosis involving the maxilla, and palate. Prioritizing research focus on optimal management of mucormycosis may reduce the morbidity and mortality associated with this debilitating infection.